Actively Recruiting
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
Led by Bristol-Myers Squibb · Updated on 2023-12-01
150
Participants Needed
1
Research Sites
245 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to describe the real-world patient and disease characteristics of metastatic non-small cell lung cancer (NSCLC) participants initiated on first-line (1L) treatment with nivolumab, ipilimumab, and platinum-based chemotherapy (NIVO/IPI/PBC), in the overall study population and the subpopulations per histological subtype of NSCLC and PD-L1 expression level.
CONDITIONS
Official Title
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants with histologically- or cytologically-confirmed metastatic NSCLC of any subtype without sensitizing EGFR mutation or ALK translocation
- Initiated first-line treatment with nivolumab, ipilimumab, and 2 cycles of platinum-based chemotherapy according to product guidelines
- Treatment started before informed consent, with no more than one nivolumab infusion given prior to consent
- Decision to prescribe treatment made before enrollment and separate from study inclusion decision
You will not qualify if you...
- Current primary diagnosis of cancer other than NSCLC requiring systemic or other treatment
- Prior systemic therapy for metastatic NSCLC
- Receiving or planned to receive investigational drug/device/intervention or received any investigational product within 1 month or 5 half-lives before starting NIVO/IPI/PBC therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Local Institution - 0001
Athens, Greece, 15561
Actively Recruiting
Research Team
B
BMS Study Connect Contact Center www.BMSStudyConnect.com
CONTACT
F
First line of the email MUST contain the NCT# and Site #.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here